JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A1720 Duvelisib (IPI-145, INK1197)

Target: PI3K

Summary: PI3K-δ/PI3K-γ inhibitor

≥20.84 mg/mL
A8306 MOG (35-55)

5 Citation

Summary: Minor component of CNS myelin

≥32.25 mg/mL
A8372 AZ3146

Summary: Mps1 inhibitor,potent and selective
A8430 Ezetimibe

1 Citation

Target: Cholesterol absorption

Summary: Cholesterol transport inhibitor

≥20.45 mg/mL
A8434 Flurbiprofen

Summary: Cyclooxygenase inhibitors

insoluble in H2O; ≥11.35 mg/mL
A8465 LY2886721

1 Citation

Target: BACE

Summary: BACE inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.52 mg/mL
A8380 Bexarotene

Target: Retinoid X receptors (RXR)

Summary: Retinoid Receptor agonist

insoluble in H2O; ≥10.35 mg/mL
A8424 Eplerenone

Summary: A mineralocorticoid receptor antagonist

insoluble in H2O; insoluble in EtOH; ≥4.6 mg/mL
A8390 Casanthranol

Summary: Mixture of anthranol glycosides

insoluble in H2O; insoluble in EtOH; ≥20.45 mg/mL
A8802 (S)-Crizotinib

4 Citation

Target: MTH1

Summary: Potent MTH1 inhibitor

≥33.33 mg/mL